Bioresorbable drug‐eluting scaffold restenosis

Publisher： John Wiley & Sons Inc

E-ISSN： 1522-726x|85|7|1162-1163

ISSN： 1522-1946

Source： CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol.85, Iss.7, 2015-06, pp. : 1162-1163

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The ABSORB bioresorbable vascular scaffold: A novel, fully resorbable drug‐eluting stent: Current concepts and overview of clinical evidence

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 1522-1946, Iss. 4, 2015-10 ,pp. : 664-677

John Wiley & Sons Inc

Access to resources Recommend Favorite

A true bifurcational stenosis treated with a bioresorbable vascular scaffold and a drug‐eluting metallic stent: Degradable meets durable

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 85, Iss. 7, 2015-06 ,pp. : 1184-1188

John Wiley & Sons Inc

Access to resources Recommend Favorite

The ABSORB bioresorbable vascular scaffold: A novel, fully resorbable drug‐eluting stent: Current concepts and overview of clinical evidence

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 86, Iss. 4, 2015-10 ,pp. : 664-677

John Wiley & Sons Inc

Access to resources Recommend Favorite

Provisional hybrid 2‐stent Strategy utilizing bioresorbable vascular scaffold and drug‐eluting metal stent: “T‐stenting and small protrusion” technique

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 1522-1946, Iss. 4, 2015-10 ,pp. : 682-685

John Wiley & Sons Inc

Access to resources Recommend Favorite

Provisional hybrid 2‐stent Strategy utilizing bioresorbable vascular scaffold and drug‐eluting metal stent: “T‐stenting and small protrusion” technique

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 86, Iss. 4, 2015-10 ,pp. : 682-685

John Wiley & Sons Inc

Access to resources Recommend Favorite